Why in hospital following transoral robotic lingual tonsillectomy?
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Why in hospital following transoral robotic lingual tonsillectomy? / Larsen, Mikkel Hjordt Holm; Channir, Hani Ibrahim; Madsen, Anne Kathrine Østergaard; Rubek, Niclas; O’Leary, Padraig; Kjærgaard, Thomas; Kehlet, Henrik; von Buchwald, Christian.
I: Acta Oto-Laryngologica, Bind 143, Nr. 9, 2023, s. 796-800.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Why in hospital following transoral robotic lingual tonsillectomy?
AU - Larsen, Mikkel Hjordt Holm
AU - Channir, Hani Ibrahim
AU - Madsen, Anne Kathrine Østergaard
AU - Rubek, Niclas
AU - O’Leary, Padraig
AU - Kjærgaard, Thomas
AU - Kehlet, Henrik
AU - von Buchwald, Christian
N1 - Publisher Copyright: © 2023 Acta Oto-Laryngologica AB (Ltd).
PY - 2023
Y1 - 2023
N2 - Background: The reported hospital length of stay (LOS) following transoral robotic surgery lingual tonsillectomy (TORS-L) is variable, with limited understanding of the factors requiring hospitalization and no evidence-based criteria for discharge. Aims/objectives: This observational cohort study investigated factors hindering discharge following TORS-L in a well-defined postoperative care program. Methods: Patients were included between August 2020 and October 2022. A discharge scheme was filled out twice daily, specifying the factor(s) for hospitalization among patients undergoing TORS-L. This trial was a sub-investigation of a national multicentre randomized clinical trial (RCT) testing the efficiency of high-dose dexamethasone on postoperative pain control. Participation in the RCT demanded admission to the fourth postoperative day as dexamethasone/placebo was given intravenously in repeated dosages till day 4 postoperatively. Results: Eighteen patients were included in the analysis. The main factor for hospitalization was nutritional difficulties, while pain was a limiting factor for discharge only on the first postoperative 1-3 days. More than half of the patients could have potentially been discharged on postoperative day 2 when omitting the RCT treatment plan in the analysis. Conclusion: The study estimates that the majority of patients may be discharged on postoperative day 2 following TORS-L.
AB - Background: The reported hospital length of stay (LOS) following transoral robotic surgery lingual tonsillectomy (TORS-L) is variable, with limited understanding of the factors requiring hospitalization and no evidence-based criteria for discharge. Aims/objectives: This observational cohort study investigated factors hindering discharge following TORS-L in a well-defined postoperative care program. Methods: Patients were included between August 2020 and October 2022. A discharge scheme was filled out twice daily, specifying the factor(s) for hospitalization among patients undergoing TORS-L. This trial was a sub-investigation of a national multicentre randomized clinical trial (RCT) testing the efficiency of high-dose dexamethasone on postoperative pain control. Participation in the RCT demanded admission to the fourth postoperative day as dexamethasone/placebo was given intravenously in repeated dosages till day 4 postoperatively. Results: Eighteen patients were included in the analysis. The main factor for hospitalization was nutritional difficulties, while pain was a limiting factor for discharge only on the first postoperative 1-3 days. More than half of the patients could have potentially been discharged on postoperative day 2 when omitting the RCT treatment plan in the analysis. Conclusion: The study estimates that the majority of patients may be discharged on postoperative day 2 following TORS-L.
KW - hospitalization
KW - recovery
KW - Transoral robotic surgery
U2 - 10.1080/00016489.2023.2265983
DO - 10.1080/00016489.2023.2265983
M3 - Journal article
C2 - 37897327
AN - SCOPUS:85175046266
VL - 143
SP - 796
EP - 800
JO - Acta Oto-Laryngologica
JF - Acta Oto-Laryngologica
SN - 0001-6489
IS - 9
ER -
ID: 395913337